675 WEST KENDALL STREET, CAMBRIDGE, MA
Market cap: $42.7B (2/09/2026)
Price: $322.98
Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
Announces Changes to Board of Directors
Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
News, Material Contracts
News, Securities Holder Rights or Indentures, Material Contracts
Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes
Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence